← Leaderboards
Iskra Pusic
Washington University
$628,090
Attributed
$628,090
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $233.3K · FY2023–25$250K$187.5K$125K$62.5K$0
'23
'24
'25
Funding mix
By agency
NIH$628,090 · 1
By mechanism
UG1$628,090 · 1
Top collaborators
No co-investigators on record.
Most similar at Washington University
Same institution · by research overlap
- Eric Martin McDade$99,265,332
- Charles W Hogue$5,161,479
- Peter Westervelt$8,274,820
- David D Tran$4,389,335
- David R Piwnica-Worms$22,122,563
Others in their field
Other Rising Stars on “Proliferating”
- Gregory Sorenson · University Of Maryland Baltimore County$9,161,697
- Hill Georgette · Integrated Laboratory Systems, Llc$8,700,000
- Kenneth Schultz · Trethera Corporation$7,234,949
- Jens Eickhoff · University Of Wisconsin-Madison$3,606,160
- Tanya L Zakrison · University Of Chicago$3,254,872
- Riccardo Gottardi · Children'S Hosp Of Philadelphia$3,232,467
Research focus
ProliferatingClinical CenterImmunologyProgramsSafetyWashingtonDoseImmuneInstitutionPreservationCorrelative StudyProphylactic TreatmentTrial DesignUniversitiesAdultCytokineExperimental StudyCell TherapyClinical TrialsIncidenceIn VitroIn VivoCardiogenic ShockCancer Therapy
Grant awards (3)
Phase III, Multicenter, Randomized, Double-Blind Study of Duvelisib as Cytokine Release Syndrome Prophylaxis in Patients with Large Cell or Mantle Cell Lymphoma Undergoing CAR T-Cell Therapies$232,941
UG1 · FY2025 · HL · contact PI
Phase III, Multicenter, Randomized, Double-Blind Study of Duvelisib as Cytokine Release Syndrome Prophylaxis in Patients with Large Cell or Mantle Cell Lymphoma Undergoing CAR T-Cell Therapies$233,250
UG1 · FY2024 · HL · contact PI
A Phase II Study of Cytokine Induced Memory-like (CIML) Natural Killer (NK) Cell Adoptive Therapy after Haploidentical Donor Hematopoietic Cell Transplantation.$161,899
UG1 · FY2023 · HL · contact PI